City of Hope Comprehensive Cancer Center
Sumanta (Monty) Kumar Pal, M.D., is an internationally recognized leader in the area of genitourinary cancers, including kidney, bladder, and prostate cancer. He is co-director of City of Hope's Kidney Cancer Program and is the head of the kidney and bladder cancer disease team at the institution.
Dr. Pal entered college at the age of 13 and began medical school at University of California Los Angeles at the age of 17. After completing his residency training at UCLA, Dr. Pal completed a fellowship program in medical oncology at City of Hope's comprehensive cancer center where he has remained on faculty since 2009.
Over that span of time, he has published more than 400 PubMed cited articles that have been featured in prominent journals including Cancer Discovery, The Journal of Clinical Oncology, The Lancet, Cancer Cell and European Urology.
Ultimately, Dr. Pal’s goal is to stimulate collaborative research across multiple departments in order to discover novel therapeutic approaches for currently incurable diseases. He has also worked to push the boundaries of personalized medicine in genitourinary cancers with several seminal publications in rare genitourinary cancers that describe unique therapeutic targets. He is the lead investigator on multiple trials, ranging from early phase 1 experiences to late stage phase 3 studies.
Exelixis: Consultant; Aveo (Individual(s) Involved: Self): Consultant; Bristol-Meyers Squibb (Individual(s) Involved: Self): Consultant; Eisai (Individual(s) Involved: Self): Consultant; Genentech/Roche (Individual(s) Involved: Self): Consultant; Ipsen (Individual(s) Involved: Self): Consultant; Osel Inc (Individual(s) Involved: Self): Other Financial or Material Support, Research support
Wednesday, March 9, 2022
9:00 AM – 11:15 AM
Wednesday, March 9, 2022
9:25 AM – 9:45 AM
Wednesday, March 9, 2022
10:13 AM – 10:21 AM
Wednesday, March 9, 2022
10:21 AM – 10:25 AM
Wednesday, March 9, 2022
10:25 AM – 11:15 AM
Thursday, September 29, 2022
9:40 AM – 11:50 AM
Thursday, September 29, 2022
10:05 AM – 10:12 AM
Thursday, September 29, 2022
10:19 AM – 10:25 AM
Thursday, September 29, 2022
11:25 AM – 11:50 AM